Studies were carried out on a line of transgenic mice that expressed an internally deleted COL2A1 gene and developed a phenotype resembling human chondrodysplasias (Vandenberg et al. 1991 . Proc. NatL. Acad. Sci. USA. 88:7640-7644. Marked differences in phenotype were observed with propagation of the mutated gene in an inbred strain of mice in that -15% of the transgenic mice had a cleft palate and a lethal phenotype, whereas the remaining mice were difficult to distinguish from normal littermates. 1-d-and 3-mo-old transgenic mice that were viable showed microscopic signs of chondrodysplasia with reduced amounts of collagen fibrils in the cartilage matrix, dilatation of the rough surfaced endoplasmic reticulum in the chondrocytes, and decrease of optical path difference in polarized light microscopy. The transgenic mice also showed signs of disturbed growth as evidenced by lower body weight, lower length and weight of the femur, decreased bone collagen, decreased bone mineral, and decreased resistance of bone to breakage. Comparisons of mice ranging in age from 1 d to 15 mo demonstrated that there was decreasing evidence of a chondrodysplasia as the mice grew older. Instead, the most striking feature in the 15-mo-old mice were degenerative changes of articular cartilage similar to osteoarthritis. (J. Clin. Invest. 1993. 92:582-595.)
Introduction
Type II collagen is the most abundant macromolecule of cartilage matrix ( 1, 2) . Therefore, it is an important component of the cartilage matrix that is formed during early development of A preliminary abstract on the whole report was presented at the Fourth International Conference on Molecular Biology and Pathology of Matrix, Jefferson Medical College, 10-13 June 1992 (Helminen et al. most skeletal structures, and it plays a critical role in bone formation through endochondral ossification. In addition, recent reports indicate that transient tracks of type II collagen fibrils appear at epitheliomesenchymal interfaces during the early development of the craniofacial system, the heart, the brain, and other organs (3) (4) (5) . In adult animals, type II collagen is a major source ofthe structural strength and resilience of hyaline cartilage in tissues such as the articular surfaces of joints and the nucleus pulposus ofthe intervertebral discs. Over the past several years, mutations in the gene for type II collagen (COL2A 1) were shown to cause several chondrodysplasias, a heterogenous group of over 150 heritable disorders that are characterized by malformations of cartilaginous structures, and degenerative changes ofjoints (see reference 6). Alleles of the COL2A1 gene were linked to arthro-ophthalmopathy or the Wagner-Stickler syndrome in about halfofa series offamilies examined (7) (8) (9) , and four mutations introducing premature termination codons into the COL2Al gene were identified as a cause of the disease (10) (11) (12) (13) . Mutations in the COL2A1 gene were also identified in a proband initially described as having a form of achondrogenesis and subsequently described as a lethal perinatal form of short-limbed dwarfism ( 14) and in four probands with spondyloepiphyseal dysplasia (15) (16) (17) ; Williams, manuscript in preparation). In addition, alleles of the COL2A 1 gene were shown to be linked to primary generalized osteoarthritis in two families (18) , and a mutation in the COL2A 1 gene was found to cause primary generalized osteoarthritis associated with a mild chondrodysplasia in another family ( 19) .
The effects of mutations in the COL2A 1 gene are usually interpreted with reference to the more extensive information now available about the effects of mutations in the two genes for type I procollagen (COLlA 1 and COLlA2). Over 100 mutations in the genes for type I procollagen have been defined as a cause of osteogenesis imperfecta (20, 21 ). Most of the mutations in severely affected probands cause synthesis ofabnormal but partially functional proa chains of the protein. The causal relationships between mutations in genes for type I procollagen and the disease phenotypes were established through linkage studies in families with milder forms ofthe disease, and extensive data on the effects ofthe mutations on the synthesis of type I procollagen by cultured skin fibroblasts, on the thermal stability of the collagen triple helix, and on the self-assembly of the collagen into fibrils (20) (21) (22) . In addition, the causal relationships between the mutations and the disease phenotypes was demonstrated directly by observations indicating that expression of mutated COL 1A A genes in transgenic mice produced phenotypes similar to human osteogenesis imperfecta
The biosynthetic pathway and structure-function properties of type II procollagen are very similar to those for type I procollagen (22, 26) . Therefore, because the mutations in the type II procollagen gene found in probands with chondrodysplasias are similar to the mutations found in the type I genes in patients with osteogenesis imperfecta, it has been reasonable to assume that the COL2A 1 mutations are a cause of the disease phenotypes. Linkage studies, however, have been performed in only a few families with mild chondrodysplasias (7) (8) (9) . In addition, cartilage is only rarely available from probands and human cartilage cells do not grow well in culture. Therefore, de- Here we have examined a line of transgenic mice that expresses an internally deleted COL2A 1 gene and that develops a phenotype resembling human chondrodysplasias (27) . The results demonstrate that the phenotype is highly variable in its severity even when the mutation is propagated in an inbred strain ofmice. In addition, the results demonstrate that after 12 or 15 mo, the transgenic mice with the mildest phenotype develop degenerative changes in joints resembling osteoarthritis.
Methods
Transgenic mice. Transgenic mice were generated using the human type II procollagen construct described by Vandenberg et al. (27) . The construct was prepared by cleaving a cosmid clone of the human COL2A1 gene (31; provided by Dr. Francesco Ramirez, Mt. Sinai School of Medicine, New York) with XbaI, SphI, and Clal to generate four fragments of the gene and then reassembling the gene in a cosmid vector without an internal 5-kb ClaI/SphI fragment. The initial cosmid clone of the gene extended from --2 kb of the promoter region to -80 bp beyond the major polyadenylation signal. Removal of the 5-kb ClaI/SphI fragment deleted a region that extended from intron 15 to intron 27 and contained 12 of the 54 exons of the gene. The internally deleted gene construct, therefore, coded for a shortened proal (II) chain with an in-frame deletion of 291 amino acids (a 1-157 to 447) of the 1,014-residue-long triple-helical domain. The transgenic mice were generated and propagated in the inbred FVB/N strain ( Fig. 1 ).
For detection of transgenic mice, one toe of the newborn mice was cut and the tissue was incubated at 55°C for 1 h in 0.1 ml of 10 mM Tris-HCl buffer containing 50 mM KCl, 5 Figure 2 . Assay of gene copy number in heterozygous transgenic mice. As described in Methods, the same primers were used to amplify a sequence of 603 bp from the COL2A1 transgene and a sequence of 557 bp from the endogenous mouse COL2A1 gene. Lane 1: Control littermate. Lanes 2-6: Heterozygous mice from line 7 generation II, IV, V, VI, and VII (See Fig. 1 ).
ate buffer (pH 7.4) for 30 min to 1 h. After buffer washings and dehydration in ascending series of ethanol solutions, the specimens were embedded in epon. Sections 50-60-nm thick were cut, and stained with uranyl acetate for 30 min, followed by staining with lead citrate for 2-4 min. They were examined with JEM 1200 EX electron microscope (JEOL, Tokyo, Japan).
For polarized light microscopy, 5 L-thick sections were cut from paraffin-embedded specimens, extracted with xylol at 370C overnight, and digested with 2 mg/ml of hyaluronidase (Sigma Chemical Co.) at 370C overnight. The specimens were then stained with sirius red (picrosirius staining). The sections were analyzed with an Ortholux 2 Pol-BK microscope (E. Leitz, Wetzlar, FRG) operated in monochromatic light (X = 591 nm filter for cartilage and X = 656 nm filter for bone; Schott, Mainz, FRG) using the de Senarmont compensation technique. Microscopic evaluation ofosteoarthritic changes. For evaluation of osteoarthritic changes in the mouse kneejoint, the grading proposed by Wilhelmi and Faust (32) was used. The scores were the following: 0 = no apparent changes; 1 = superficial fibrillation, striation ofcartilage (or cystic change); 2 = injuries limited to uncalcified cartilage; 3 = defects extending into calcified cartilage; 4 = deep defects extending into the subchondral and/or trabecular bone. The left knee joint of mouse was serially sectioned in frontal plane and the sections were investigated after staining with both picrosirius and safranin 0. The kneejoint was divided into two compartments. The medial condyles of femur and tibia formed the medial compartment. The lateral compartment was made up by the lateral femoral and tibial condyles.
X-ray analysis, skeletal staining, and spontaneous movements. Xray analysis of the skeleton was performed with a cabinet x-ray system (Cabinet; Hewlett-Packard Co., McMinnville, OR). For further analysis of skeletons, specimens were differentially stained with alcian blue for cartilage and alizarin red S for bone followed by alkali digestion (33) . Spontaneous movements ofthe mice in their own cages at the 3-and 15-mo intervals were recorded on two consecutive days by a small animal movement monitor (model 152-01, Coulibourn Instruments, Lehigh Valley, PA).
Assay ofcollagen and bone mineral. Bone tissue was homogenized with mechanical grinder (Tissuemizer, Tekmar Co., Cincinnati, OH) followed by further homogenization with a motor-driven sintered glass homogenizer. The homogenate was first dialyzed for 4 d against 0.5 M EDTA (pH 8.0) followed by dialysis against distilled water for 1 d. A sample of the homogenate was hydrolyzed in 6 N HCI at 100IC overnight and the collagen hydroxyproline was assayed by the method of Woessner (34) . To determine the mineral (ash) weight, the bones were wrapped in aluminum foil, ashed in oven at 600C (Thermolyne type 1400 furnace, Barnstead/Thermolyne, Dubuque, IA) for 18-24 h and weighed. Collagen and mineral assays were separately performed on the diaphyseal and epiphyseal parts of the femur. The epiphyseal bone parts contained most, if not all, of the growth cartilage.
Biomechanical testing. For biomechanical testing of the diaphysis, the three-point bending test was performed with an instrument designed for this purpose (Universal Testing Machine; Instron Corp., Canton, MA) as described by Kiebzak et al. (35) . The ends of the diaphysis were supported by two fulcra separated by a distance of 5 mm. Force was applied at the midshaft and perpendicular to the long axis of the diaphysis by a blunt indenter edge moving at a constant speed of 10 mm/min. A force-deformation curve was obtained from a recorder, and the load to bone failure, stiffness, and total energy needed to break the bone was measured from the graph. The load to bone failure (Nt) was assayed as the peak of the curve. Deformation at the break point was estimated from the curve by measuring the distance between the start point of loading and the bone break on the abscissa. The stiffness (Nt/in) ofthe bone was determined from the slope ofthe force-deformation curve. The area underneath the curve was taken as the energy (Ntm) needed to break the bone.
Results
The line of transgenic mice. Several lines of transgenic mice were prepared that expressed an internally deleted construct of the human COL2A 1 gene (27) . The construct was designed so as to cause synthesis of shortened proa (II) chains that would associate with and become disulfide-linked to normal proa 1(11) chains synthesized from the endogenous mouse COL2A 1 gene. As a result, expression of the gene would cause depletion of the mouse type II procollagen because fibrillar procollagens containing both markedly shortened and fulllength proa (11) chains cannot fold into a stable triple helix and are degraded (21, 22, 26) . The phenotypes of the transgenic mice from different lines varied from normal to a lethal chondrodysplasia characterized by dwarfism, delayed mineralization, and cleft palate (27) . The line selected for study here was originally designated as line 7 (27) . To develop a breeding stock, the Fo female founder of line 7 in the FVB/N inbred strain was mated with a wildtype FVB/N male and the line was propagated in the same inbred FBV/N strain ( Fig. 1) . Also, brother-sister matings were carried out in the third and fourth generations (III and IV in Fig. 1 ) in an attempt to obtain homozygous mice, i.e., mice in which the randomly inserted exogenous gene was present on both copies of the same chromosome. As reported previously (27) , Southern blot assays with a mixture of two probes suggested that the copy number in the founder of line 7 and in the heterozygous progeny was about two. An independent assay was developed here using the PCR under conditions in which the same primers amplified a fragment of a different size from each gene. The results confirmed that the copy number was two in heterozygous transgenic mice from the line (Fig. 2) . The copy number did not vary with propagation ofthe line through at least seven generations. The value for the ratio of the transgene to the endogenous gene as assayed by the PCR technique was 0.88±0.11 SD in eight putative heterozygous mice randomly selected from generations II-VII (Fig. 1) . A few of the progeny from the brother-sister matings in generation III and IV (Fig. 1) were homozygotes as judged by an increase in copy number to about four (not shown). However, the mice with the higher copy number died within a few days of birth. Also, when viable progeny of the brother-sister matings in generations III and IV were mated to wild-type FVB/N mice, none gave litters in which all the mice were transgenic. Therefore, none of the viable progeny of the brother-sister matings was homozygous by this stringent genetic test.
Variable phenotype in the transgenic mice. Previous observations on line 7 suggested that expression of the transgene in the inbred strain FVB/N produced a variable phenotype in that about one-third ofthe heterozygous transgenic mice developed a lethal chondrodysplasia, whereas about two-thirds were viable (27 FVB/N strain ( Fig. 1) remainder died within the next 24 h. There was no marked gender preference in transmission of the phenotype in that the incidence of cleft palate and the lethal phenotype was the same when the line was propagated through male or the female transgenic mice. However, there was a small decrease in the male/ female ratio in the progeny oftransgenic to transgenic matings (Table I) . Because viable homozygous mice were not obtained, all further studies were carried out on heterozygous mice generated from the transgenic mice designated as BM2 and BM3 in Fig. 1 (Fig. 3) . At 12 and 15 mo, the male transgenic mice remained slightly smaller in weight, but the weight ofthe female transgenic mice approached the weight of normal littermates (Fig. 3 ). They were indistinguishable in appearance from normal littermates.
Femurs from the transgenic mice weighed less, were shorter, and had an increased ratio ofwidth to length compared with that of normal littermates (Table II) . The differences, however, were slightly less in the older mice. In 3-mo-old transgenic mice, the weights of the femurs were 14% less than controls (P < 0.001) and the lengths ofthe femurs were 1 1% less (P < 0.001). In 15-mo-old transgenic mice the differences were 1% (P < 0.01 ) and 8% (P < 0.001), respectively. A similar trend was seen in the ratio of the width to the length of the femurs in that the P value for the difference was < 0.001 for 3-mo-old mice and < 0.01 for 15-mo-old mice.
Microscopy ofcartilage matrix. As reported previously, microscopic examination of sections of nasal septum, spine, and elbow joint from l-d-old mice from line 7 demonstrated a decrease in collagen fibrils in the cartilage matrix (27) . Here the previous examinations were extended to compare cartilage from 1-d-, 3-mo-, and 15-mo-old transgenic mice.
In 1 -d-old transgenic mice, collagen fibrils appeared less abundant, shorter, and more kinked in nasal septum, in the growth plate of tibiae and in condyles of the femur than in normal littermates (Fig. 4 and Table III) . Also, the chondrocyte columns ofthe growth plate appeared less aligned. In addition, increased dilation of the cisternae of the rough endoplasmic reticulum was apparent in most chondrocytes.
In 3-mo-old mice, the same changes were present but less I - marked. There was dilation ofthe cisternae ofthe rough endoplasmic reticulum, particularly in chondrocytes in the growth plate (Fig. 5) . The decrease in collagen fibrils in the cartilage matrix was no longer as apparent as in 1 -d-old mice. In general, the differences were less apparent than in cartilage from the 1-d-old transgenic mice (Table III) . In the 15-mo-old mice, the differences from control littermates were still less apparent (Table III) .
Measurements of polarized light retardation by cartilage matrix demonstrated a similar trend. In 1-d-old mice, differences were seen in the optical light path ofpolarized light in the cartilage matrix of the nasal septum and growth plate cartilage (Table IV) . In 3-mo-old mice, similar differences were seen in the cartilage matrix of nasal septum, the growth plate, the deep zone of articular cartilage, and the superficial zone of articular cartilage ( Fig. 6 and Table IV ). In 15-mo-old mice, the differences were still present but less significant in three of the same tissues (P value of < 0.01 instead of < 0.001 ) and no difference was seen in the superficial zone of articular cartilage from regions of the tissue that appeared normal.
Microscopy ofarticular surfaces. Although the changes in cartilage matrix were less apparent in the older transgenic mice than in the younger transgenic mice, there were more marked changes in the articular surfaces ofthe knee, particularly in the medial compartment. 1 of 12 normal littermates had cartilage defects extending into the subchondral bone and another normal mouse had a defect confined to the uncalcified cartilage (Fig. 7) . In contrast, 4 of 12 transgenic mice had defects extending to the subchondral bone and three other transgenic mice had superficial fibrillation with either striation ofthe cartilage, a lesion in the uncalcified cartilage, or a cartilage defect extending to the calcified articular cartilage. The osteoarthritic changes were apparent by light microscopy (Fig. 8) and by electron microscopy (Fig. 9) . The differences between 15-mo- 6-12. * P < 0.01, significant; § P < 0.001, highly significant difference between the transgenic and control groups (Mann-Whitney's U test). 1 l Measured in regions of cartilage that appeared normal.
old normal littermates and transgenic mice (Fig. 7) was significant with a P value of < 0.05 as evaluated by the Kruskal-Wallis one-way Anova test. In 3-mo-old transgenic mice, degenerative changes were seen in the lateral compartment of the knee instead of the medial compartment. Four ofthe transgenic mice, but only one of the normal littermates, demonstrated either a cleft within the articular cartilage or a loss of an uncalcified cartilage fragment (not shown).
Osteoarthritic changes demonstrable by x-ray. To examine further for osteoarthritic changes, x-ray films were prepared from knee joints from 12-and 15-mo-old heterozygous transgenic mice (Fig. 10) , and they were evaluated by a clinical radiologist without access to the key (Table V) . In 12-mo-old mice, osteoarthritic changes were seen in the knee joint of about twice as many of the transgenic mice as of normal littermates. Among the 15-mo-old mice, osteoarthritic changes were seen about three times more frequently among male transgenic mice than in normal male littermates. There was no apparent difference among the 15-mo-old females.
Spontaneous movements as an indication ofjoint degeneration. As a further indication ofjoint changes in the transgenic mice, the spontaneous movements of the mice were evaluated on two consecutive days. With 3-mo-old mice, there was no significant difference between transgenic mice and normal littermates (Table VI) . With 15-mo-old mice, however, the number of spontaneous movements in the transgenic mice was less than in control littermates (P < 0.01). AV. In the 15-mo-old transgenic mice, however, the decrease in mineral was proportionately less than the decrease in collagen content. As a result, there was a marked increase in the ratio of mineral to collagen both in the intact femur and in the diaphysis (P < 0.001 ).
Biomechanical properties of bone of the transgenic mice. Measurements of the biomechanical properties of femoral bone with a three-point bending test demonstrated that there was a decrease in the stiffness, in the force required to break the bone, and in the total energy for breakage (Table VIII) . The largest difference observed was in the total energy for breakage in the 3-mo-old transgenic mice (P < 0.001 ), but there were no simple trends in comparison of the other values for 3-and 15-mo-old transgenic mice.
Discussion
The results here speak to two general issues. One is the marked variation in phenotypes previously observed in families with mutations in collagen genes. The other is the different roles of type II collagen in early development and in the mature organism.
The mutated COL2A 1 gene used in the experiments described here was based on several mutations in the genes for type I procollagen that produced in-frame deletions of codons for the repeating -Gly-Xaa-Yaa-amino acid sequences of the collagen triple helix and cause lethal variants of OI (20) (21) (22) . Because the collagen triple helix is formed by a series of hydrogen bonds and water bridges that link -Gly-Xaa-Yaa-sequences Comparisons of young with 12-and 15-mo-old mice demonstrated that even among the mice with the mild phenotype there was decreasing evidence of a chondrodysplasia as the mice grew older. The older mice were still significantly different from controls in length, weight, mineral content, and collagen content of femurs. The most striking finding in the 15-moold transgenic mice, however, was the marked erosion ofarticular surfaces that was found in only a few normal littermates. The microscopic changes in articular surfaces were in part reflected by x-ray evidence of degenerative changes in the knee and by a decrease in spontaneous movements in the mice. Therefore, a major manifestation of expression of transgene in the older mice was degenerative changes of articular cartilage * Mean±SD for 14-17 mice except that only six or seven 3-mo-old mice were used for assays of epiphyses. * P < 0.05, almost significant; § P <0.01, significant; "P <0.001, highly significant difference between the transgenic and control groups (Student's t-test and Mann-Whitney's U test). similar to osteoarthritis. The results suggest that the expression of the mutated gene in part made it possible to distinguish the two apparent functions of hyaline cartilage, one to serve as a temporary template for the development of skeletal structures and the other to provide the organism with permanent skeletal components that are flexible but resilient to compression. In addition, the results support the hypothesis that there may be phenotypic overlap between relatively rare diseases of connective tissue such as chondrodysplasias and some subsets ofmore common disorders such as primary generalized osteoarthritis (36) .
Chemical assay on femoral bone demonstrated a decrease in both the mineral content and total collagen content, observations that are consistent with many previous observations suggesting a critical role for type II collagen in endochondral ossification. Surprisingly, however, there was an increase in the ratio of mineral to collagen. The increase was seen in 15-moold mice and not in 3-mo-old mice, and it may well reflect a compensatory mechanism to increase the strength of bone.
One striking observation here was the marked differences in phenotype observed with propagation ofthe mutated gene in an inbred strain of mice. Examination of 283 transgenic mice demonstrated that 15% had a cleft palate whereas the remainder did not. Moreover, the mice with a cleft palate died on the day of birth or shortly thereafter, apparently because they were unable to nurse. Many of the remaining viable 85% of transgenic mice were not distinguishable from normal littermates on the basis of appearance, and at day 1 they did not on average weigh significantly less than control littermates. Microscopy of cartilage from the l-d-old viable transgenic mice revealed changes similar to those seen in nonviable mice, but it was apparent that the phenotype varied from a lethal chondrodysplasia to a very mild disorder. There was no correlation between phenotype and sex of the parents or progeny, and the same variation was seen with multiple matings within the same inbred line. Therefore, it is difficult to ascribe the phenotypic variation to differences in the genetic background of the mice (37) . Instead, it is more likely explained by variations in uterine environment or stochastic events during development. We have recently observed similar variations in a phenotype of fragile bones in an inbred line oftransgenic mice expressing an internally deleted COLlA 1 gene (38) .
